Rosen, a Leading Investor Rights Law Firm, Encourages Regeneron Pharmaceuticals, Inc.
Rosen Law Firm Reminds Regeneron Pharmaceuticals Investors of Lead Plaintiff Deadline January 23, 2025 NEW YORK, NY / ACCESS Newswire / January 23, 2025 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the…